Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#257 Doxorubicin, Etoposide and Cisplatin as first-line Treatment in Advanced Adrenocortical Carcinoma

Introduction: Adrenocortical carcinoma (ACC) is a rare cancer with poor prognosis in advanced setting due to its low chemosensibility. Mitotane and cisplatin-based regimens are the most frequently used treatments.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca F, Vieitez J, Crespo G, Frunza M, Izquierdo M,

Keywords: adrenocortical carcinoma, chemotherapy, cisplatin-regimen, Doxorrubicin, Etoposide, Mitotane,

#253 Description and Treatment of GEP NETs in a Spanish Hospital During 10 Years

Introduction: In our area the GEP NET incidence is similar to that of gastric and exocrine pancreatic cancers consequently being important to know their characteristics and the most convenient therapeutic approach.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca P, Vieitez J, Galvan J, Crespo G, Frunza M,

Keywords: gastroenteropancreatic neuroendocrine tumors, histology, chemotherapy, streptozocin-based regimen,

#241 One-year Response to Everolimus in a Case of Advanced Pancreatic NET

Introduction: A stage IV pancreatic NET (30 mitoses/10 PF and Ki-67 index=40%) with liver and peritoneal metastases was diagnosed in a 35-year-old woman in June 2008. Characteristics: ECOG2 and CgA 1701 ng/ml.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca P, Vietez J, Galvan J, Crespo G, Astudillo A,

Keywords: pancreatic neuroendocrine tumor, Everolimus, Somatostatin Analogues, chemotherapy,